Nanomi Honored with CMO Award for Pioneering Drug Delivery Technology

Nanomi B.V., a Dutch subsidiary of Lupin Limited, has been awarded the prestigious CMO Award for Life Science Leadership in Drug Delivery. The company's innovative Microsieve technology has revolutionized the production of long-acting release medicines, allowing for highly controlled and cost-effective manufacturing of microspheres and nanoparticles. Nanomi's biodegradable monodisperse particles enable easier injection, reduced pain, and tailored release profiles for pharmaceutical compounds. This achievement underscores Nanomi's commitment to advancing pharmacotherapy and improving patient outcomes. The award recognizes Nanomi's significant contributions to the life sciences industry and serves as motivation for continued innovation in drug delivery systems.

 

Source: PR Newswire